Deposition of amyloid proteins in the epicardial coronary arteries of 58 patients with primary systemic amyloidosis

被引:33
|
作者
Wittich, Christopher M.
Neben-Wittich, Michelle A.
Mueller, Paul S.
Gertz, Morie A.
Edwards, William D.
机构
[1] Mayo Clin & Mayo Fdn, Div Gen Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Div Hematol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Anat Pathol, Rochester, MN 55905 USA
关键词
amyloidosis; coronary artery; pathology; vasa vasorum;
D O I
10.1016/j.carpath.2006.09.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: We sought to determine the distribution and the effect of amyloid on epicardial coronary arteries in patients with primary cardiac amyloidosis. Methods: We reviewed pathologic specimens taken after autopsy or cardiac transplantation from 58 patients with primary cardiac amyloidosis. Patients were seen from 1981 to 2000. Multiple sections of epicardial coronary arteries (left anterior descending artery, left circumflex artery, and right coronary artery) were examined to determine the degree of amyloid deposition in the intima, media, adventitia. and vasa vasorum (vasa vasorum are nutrient arteries for the coronary arteries themselves). Results: In 56 of 58 patients (97%), amyloid was present in epicardial coronary arteries. Amyloid was identified in all artery layers (intima, media, and adventitia), and more patients had amyloid in the adventitia. However, amyloid did not cause intraluminal obstruction of epicardial coronary arteries in any patient. The vasa vasorum had considerable deposits and, in many patients, were obstructed by amyloid. Patients with obstruction of the vasa vasorum were significantly more likely to have obstructive intramural coronary amyloidosis than patients without vasa vasorum obstruction (P=.002). Conclusions: The epicardial coronary arteries of patients with primary cardiac amyloidosis had extensive amyloid deposition. This deposition, however, did not lead to obstruction of epicardial coronary arteries and therefore did not contribute to ischemic syndromes observed in these patients. Obstruction of the vasa vasorum was associated with obstructive intramural coronary amyloidosis. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [31] Amyloid deposition of systemic myeloma-associated amyloidosis excludes actinic elastotic material
    Wada, N
    Fujimoto, N
    Komatsu, T
    Tajima, S
    Ishibashi, A
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2002, 12 (06) : 607 - 608
  • [32] SERIAL ECHOCARDIOGRAPHIC OBSERVATIONS IN PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS - AN INTRODUCTION TO THE CONCEPT OF EARLY (ASYMPTOMATIC) AMYLOID INFILTRATION OF THE HEART
    CUETOGARCIA, L
    TAJIK, AJ
    EDWARDS, WD
    GREIPP, PR
    CALLAHAN, JA
    SHUB, C
    SEWARD, JB
    [J]. MAYO CLINIC PROCEEDINGS, 1984, 59 (09) : 589 - 597
  • [33] AMYLOID RENAL-TRANSPLANTS IN 2 PATIENTS WITH PRIMARY AMYLOIDOSIS
    DORMAN, SA
    GAMELLI, RL
    TRAINER, TD
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1980, 74 (04) : 502 - 502
  • [34] Primary systemic amyloidosis in patients with Waldenström macroglobulinemia
    Saurabh Zanwar
    Jithma P. Abeykoon
    Stephen M. Ansell
    Morie A. Gertz
    Angela Dispenzieri
    Eli Muchtar
    Surbhi Sidana
    Nidhi Tandon
    S. Vincent Rajkumar
    David Dingli
    Ronald Go
    Martha Q. Lacy
    Taxiarchis Kourelis
    Thomas E. Witzig
    David Inwards
    Francis Buadi
    Wilson Gonsalves
    Thomas Habermann
    Patrick Johnston
    Grzegorz Nowakowski
    Robert A. Kyle
    Shaji Kumar
    Prashant Kapoor
    [J]. Leukemia, 2019, 33 : 790 - 794
  • [35] DILATATION OF EPICARDIAL CORONARY-ARTERIES BY INTRAVENOUS DILTIAZEM IN PATIENTS WITH CORONARY HEART-DISEASE
    BONZEL, T
    WOLLSCHLAGER, H
    LOLLGEN, H
    MUNZEL, T
    ZEIHER, A
    TARNOWSKA, R
    WEHRLE, B
    JUST, H
    [J]. ZEITSCHRIFT FUR KARDIOLOGIE, 1985, 74 (04): : 238 - 244
  • [36] Is there a role for invasive assessment of the coronary microcirculation in patients with unobstructed epicardial coronary arteries in clinical practice?
    Khan, Tina Z.
    de Silva, Ranil
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 267 : 46 - 47
  • [37] Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries
    Mangieri, E
    Macchiarelli, G
    Ciavolella, M
    Barilla, F
    Avella, A
    Martinotti, A
    DellItalia, LJ
    Scibilia, G
    Motta, P
    Campa, PP
    [J]. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1996, 37 (04): : 375 - 381
  • [38] EFFECTS OF KETANSERIN ON EPICARDIAL CORONARY-ARTERIES AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH STABLE ANGINA
    TOUSOULIS, D
    DAVIES, G
    TENTOLOURIS, C
    APOSTOLOPOULOS, T
    KYRIAKIDES, M
    TOUTOUZAS, P
    [J]. EUROPEAN HEART JOURNAL, 1994, 15 (07) : 922 - 927
  • [39] Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemically proven myocarditis
    Klein, RM
    Schwartzkopff, B
    Strauer, BE
    [J]. AMERICAN HEART JOURNAL, 1998, 136 (03) : 389 - 397
  • [40] Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies
    Solomon, A
    Weiss, DT
    Wall, JS
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (06) : 853 - 860